global next generation sequencing market, the Sanger Sequencing market and provides specific focus on the clinical diagnostic opportunities of the NGS technology.
Dallas, Texas (PRWEB) October 11, 2014
Next Generation Sequencing (NGS) technology has emerged as a higher throughput and much cheaper alternative of sequencing DNA than traditional Sanger Sequencing. NGS can be used primarily to identify genes responsible for inherited skin disease, to detect mutations that play a role in diseases such as cancer and to determine RNA expression level. The use of NGS technology in clinical research and genome functions is constantly increasing and there are many clinical diagnostic opportunities for next generation sequencing such as in oncology screening, parental screening, Alzheimer diseases, multiple sclerosis etc.
Company Profiles: Illumina, Life Technology, Roche and Pacific Bioscience
Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=315881.
The growth of the overall NGS market is driven by continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs. However factors such as mismatch between discovery and interpretation of samples, clinical translation of genomic discoveries, difficulty in finding samples to sequence and storage of sequence data hinders the growth of the market. In addition, factors such as high reliability on grants and funding from the government are still a challenge. The opportunities for the growth of this market include developments in the pre-sequencing, cloud computing, and NGS bioinformatics solutions. Next generation sequencing technology is set to revolutionize applied markets like diagnostics, drug discovery, biomarker discovery, personalized medicine, agriculture and animals research in the near future.
The report titled "Global Next Generation Sequencing Market: Trends and Opportunities (2013-2018)" analyzes the potential opportunities and significant trends in the global Next Generation Sequencing market. The report also provides detailed analysis of the global next generation sequencing market, the Sanger Sequencing market and provides specific focus on the clinical diagnostic opportunities of the NGS technology. The report also profiles and analyzes the business strategies of the leading companies operating in the segment.
List of Tables
Table 1: Comparison of Next Generation Sequencing (NGS) and Sanger Sequencing
Table 2: Comparison of NGS vs. Traditional Sanger Sequencing on the Basis of Technology
Table 3: Comparison of Different Methods of Next Generation Sequencing
Table 4: Diagnostic Opportunity for Next Generation Sequencing
Table 5: NGS Based Test with Clinical Application
Table 6: Comparison of High Throughput and Low Throughput Cost by Company
Table 7: Comparison of High Throughput and Low Throughput Performance by Company
Table 8: Uses of Different Next Generation Systems
Table 9: Comparison of Next Generation Technologies
Table 10: Next Generation Sequencing Products Release Timeline by Product Family
Explore more reports on Biotechnology Market at http://www.marketreportsonline.com/cat/biotechnology-market-research.html.
MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the biotechnology market, MarketReportsOnline.com offers research studies on medical devices, chemicals, agriculture, environment, energy and power, agriculture, retail, it & telecommunication, semiconductor and electronics, food and beverages, advanced materials, consumer goods, mining & utilities, travel & hospitality, healthcare and much more.